reviewJAMAApr 22, 2019GREEN OA

Metformin in 2019

Memorial Sloan Kettering Cancer Center · Yale University

PubMed
Indexed incrossrefpubmed

Abstract

Metformin is the first-line pharmacologic treatment for type 2 diabetes and the most commonly prescribed drug for this condition worldwide, either alone or in combination with insulin or other glucose-lowering therapies. Metformin is a biguanide, a drug class of herbal origin that has been widely used to treat diabetes since the 1950s.(1,2) Two other biguanides were withdrawn from clinical use because they caused lactic acidosis. Metformin was also taken off the US market due to concerns over lactic acidosis, but it subsequently has been proven safe and effective in lowering glucose levels and was reintroduced in 1995. Optimal metformin use requires clear understanding of its effects, dosing, safety, and…

Citation impact

470
total citations
FWCI
17.18
Percentile
100%
References
11
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Metformin
  • Traditional medicine
  • Intensive care medicine
  • Diabetes mellitus
  • Endocrinology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.